Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GenSci, Osteotech musculoskeletal news

GNS will withdraw permanently its patent infringement claims related to OSTE's Grafton Demineralized

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE